Meet SI-BONE
Advancing the diagnostic understanding of the sacroiliac joint and minimally invasive surgery for certain causes of SI joint disorders.
SI-BONE® was founded in April 2008, as a spin out when Wright Medical bought INBONE Technologies. INBONE, with the ENDO-FUSETM Intra-Osseous Fusion System, was founded by Dr. Mark Reiley, the inventor of kyphoplasty a treatment for vertebral compression fractures.
In this section
Company
Spotlight
Mission
Helping patients rise up and reach for the stars
Vision
Working together as the global leader to make sacropelvic conditions universally recognized and effectively treated through innovation, evidence, education, and advocacy
Values
We value each employee, customer, and business partner
We work together to solve problems, having the courage to disagree, debate, and then commit
We do our best work
We embrace creative solutions and believe what worked yesterday may not work today
We strive to learn from the world around us
We do not compromise on delivering the best outcomes for patients
SI-BONE is a global leader in technology for surgical treatment of sacropelvic disorders. In 2009, SI-BONE pioneered a proprietary minimally invasive surgical system, the iFuse Implant System®, to fuse the SI joint and treat SI joint dysfunction. Tens of thousands of patients have subsequently been treated with iFuse by thousands of trained physicians around the world. A unique body of clinical evidence supports the use of SI-BONE’s technologies, including two randomized controlled trials and over 135 peer-reviewed publications. SI-BONE has leveraged its leadership in minimally invasive SI joint fusion to commercialize novel solutions for adjacent markets, including adult deformity, spinopelvic fixation, and pelvic trauma. The expanded iFuse Technology® platform now includes iFuse 3D™, iFuse TORQ®, iFuse TORQ TNT™, and iFuse Bedrock Granite®.
SI-BONE is managed by an experienced team of executives from Kyphon, Medtronic, INBONE, Saint Francis and several start-up orthopedic and spine companies.
Prevalence
According to the National Institute of Neurological Disorders and Stroke (a division of NIH), "Americans spend at least $50 billion each year on low back pain." Low back pain is the most common cause of job-related disability and a leading contributor to missed work. Several leading orthopedic publications over the last few years have stated that anywhere from 15-30% of all low back pain is SI joint in origin.1,2,3,4,5
According to a study by Bernard and Kirkaldy-Willis, over twenty two percent (22%) of individuals who presented with lower back pain actually had sacroiliac (SI) joint pain.1 A wealth of published clinical literature indicates that sacroiliac (SI) joint pain frequently mimics discogenic or radicular low back pain, resulting in many patients receiving lumbar fusion instead of sacroiliac (SI) joint fusion.26
SI-BONE is focused on helping patients in one of the most under-served, under-diagnosed, and under-treated areas in orthopedics, the sacroiliac (SI) joint. The iFuse Implant System is intended for sacroiliac fusion for conditions including sacroiliac joint dysfunction that is a direct result of sacroiliac joint disruption and degenerative sacroiliitis. This includes conditions whose symptoms began during pregnancy or in the peripartum period and have persisted postpartum for more than 6 months. The iFuse Implant System is also intended for sacroiliac fusion to augment immobilization and stabilization of the sacroiliac joint in skeletally mature patients undergoing sacropelvic fixation as a part of a lumbar or thoracolumbar fusion.
SI-BONE is a proud member of the following organizations: